Response to Comments: MolDX: Xpresys Lung

This document is an administrative response-to-comments notice for the MolDX: Xpresys Lung (LCD DL37054) and contains only timeline information (comment period, notice period, and final LCD date). It does not specify clinical coverage indications, limitations, or frequency limits; the LCD became final on 2017-09-29.

"Public comment period for MolDX: Xpresys Lung LCD ran 2017-02-08 through 2017-04-10; notice period 2017-08-14 through 2017-09-28; LCD became final 2017-09-29."

Sign up to see full coverage criteria, indications, and limitations.